Close Menu

NEW YORK (GenomeWeb) – Sequenom will move its laboratory operations in Grand Rapids, Michigan to its facility in Raleigh-Durham, North Carolina, the company said today.

Sequenom's cystic fibrosis carrier screen test, which previously ran out of its Grand Rapids lab, will now be performed in the North Carolina location. In addition, as part of the consolidation, the firm said it would discontinue its SensiGene Fetal RHD test.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.